Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Ginseng Corp (KGC) is the world's leading manufacturer of Korean Red Ginseng products, most notably under its flagship brand CheongKwanJang. Founded with a heritage dating back to 1899 as a government-controlled monopoly, the company specializes in the cultivation, processing, and global distribution of high-quality Panax ginseng. KGC operates extensive R&D facilities focused on the pharmacological effects of ginsenosides, targeting areas such as immune support, fatigue recovery, and cognitive health. The company maintains rigorous quality control standards, including a 290-item safety test protocol, and operates the world's largest ginseng manufacturing facility in Buyeo, South Korea. KGC's product portfolio spans traditional extracts, tonics, and modern functional health supplements distributed in over 40 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korean Ginseng Extract.